Sarah Sheikh
Psychiatry & Neurology / Neurology
Credentials: · ·
History
- 2004–2008
OXFORD UNIV, OXFORD
Research
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
New England Journal of Medicine · 2012 · 1,397 citations
The Lancet Neurology · 2019 · 153 citations
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
Journal of Multiple Sclerosis · 2015 · 83 citations
- KD
7 papers
5 papers
4 papers
- AD
3 papers
- AA
3 papers
- JP
3 papers
3 papers
3 papers
